Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

US Stimulus Plan And UK Q4 GDP In Focus

Published 07/02/2021, 06:33

The US will remain focused on Biden’s $1.9 trillion stimulus plan this week, while the UK is facing a Q4 GDP reckoning.

US
Until the stimulus package is enacted – the Democrats want to sign the American Rescue Plan into law by March 14th – the progress of the bill is going to remain near the top of the list in terms of investors’ concerns.

Reflecting the game-changing nature of January’s Senate race victories in Georgia, the Democrats passed a budget resolution – with Vice President Kamala Harris casting the deciding vote – allowing the in-power party to push forward with the budget reconciliation process. The Biden administration isn’t guaranteed to go down this path; the President is still seeking a bipartisan solution. However, if the Republicans don’t play ball, the framework is in place for the Democrats to move forwards on their own.

Investors will also be on the lookout for any hiccups in the vaccine rollout stateside. Currently around 1.3 million Americans are being vaccinated daily, with more than 30 million people having had received their first dose. However, Dr Anthony Fauci has said that there is still ‘much more demand than there is supply’. A vaccine shortage like we have seen in the Eurozone could undermine confidence in the US markets.

Beyond that, the economic calendar doesn’t have too much to offer this week. The JOLTS job openings figure is out on Tuesday, followed by inflation – which rose to 0.4% last month – on Wednesday, jobless claims on Thursday and consumer sentiment on Friday.

While the big tech stocks have all reported, there are still a fair few recognisable names left to update investors this earnings season.

One of those firms is Twitter, which posts its fourth quarter figures on Tuesday. The social media company’s Q3 numbers were a bust, unveiling 187 million active daily users against the 195 million forecast – that was an addition of just 1 million new users across the quarter. If the pace of additions didn’t pick up during Q4, the stock could be in trouble.

The rest of the calendar sees Coca-Cola (NYSE:KO) and General Motors (NYSE:GM) report on Wednesday, followed by Disney and PepsiCo (NASDAQ:PEP) on Thursday.

UK
The undoubted highlight of the UK’s trading week is Friday’s first glimpse at fourth quarter growth.

Estimates place Q4 GDP at just 0.9%, a colossal downturn from the 16% rebound see in the third quarter. However, that might be just fine with investors; at points it seemed a lock that the UK economy would contract in the final 3 months of 2020.

Coming alongside the GDP data this Friday are the construction output, goods trade balance, industrial and manufacturing production readings.

As for corporate updates, Electrocomponents (LON:ECM) is up on Monday, with Ocado (LON:OCDO), Micro Focus International (LON:MCRO) and Bellway (LON:BWY) on Tuesday, Dunelm Group PLC (LON:DNLM) on Wednesday, and AstraZeneca PLC (LON:AZN) (NASDAQ:AZN) on Thursday.

Eurozone
Germany dominates the Eurozone’s economic calendar this week, with industrial production on Monday, trade balance on Tuesday and inflation on Wednesday. The country will also feature heavily in Thursday’s EU economic forecasts.

Elsewhere there is the region-wide Sentix investor confidence number on Monday, and Italian, French and Eurozone-wide industrial production on Tuesday, Wednesday and Friday respectively.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"Disclaimer: Spreadex provides an execution only service and the comments above do not constitute (or should not be construed as constituting) investment advice or recommendations, or a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any person placing trades based on their interpretations of the above comments does so entirely at their own risk. Spreadex Ltd is a financial and sports spread betting and sports fixed odds betting firm, which specialises in the personal service and credit area. Founded in 1999, Spreadex is recognised as one of the longest established spread betting firms in the industry with a strong reputation for its high level of customer service and account management.

In relation to spread betting, Spreadex Ltd is authorised and regulated by the Financial Conduct Authority. Spread betting carries a high level of risk to your capital and can result in losses larger than your initial stake/deposit. It may not be suitable for everyone, so please ensure you fully understand the risks involved."

Original Post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.